MedPath

A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y

Phase 2
Terminated
Conditions
Painful Diabetic Neuropathy
Interventions
Drug: GRT3938Y
Drug: Placebo
Registration Number
NCT01056315
Lead Sponsor
Grünenthal GmbH
Brief Summary

This trial is assessing the analgesic efficacy and safety of a new central analgesic in subjects with pain due to diabetic peripheral neuropathy (DPN).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
553
Inclusion Criteria
  • Symmetrical painful diabetic peripheral neuropathy
Exclusion Criteria
  • History of hypersensitivity, allergy or contraindication to opioids and acetaminophen
  • Confounding painful conditions
  • Significant vascular disease
  • History or risk of seizure
  • Chronic disease that might effect drug absorption, distribution, metabolism, or excretion
  • Female subjects who are being pregnant or breastfeeding
  • Evidence or history of alcohol, medication, or drug abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
A GRT3983YGRT3938YParticipants randomly assigned to receive GRT3983Y.
B PlaceboPlaceboParticipants randomly assigned to placebo.
Primary Outcome Measures
NameTimeMethod
Average Pain IntensityBaseline; last 7 days of 12-week maintenance

The primary efficacy endpoint is the change from baseline in the mean of the daily average pain intensity scores (on an 11-point NRS) over the last 7 days of the 12-week maintenance (Week 16).

Secondary Outcome Measures
NameTimeMethod
Short Form 36 Health Survey (SF-36®): Changes From Baseline to Day 29, Day 71 and Day 113 (Final Visit).Baseline, Day 29, Day 71 and Day 113.
Hospital Anxiety and Depression Scale: Changes From Baseline to Day 29, Day 71 and Day 113 (Final Visit).Baseline, Day 29, Day 71 and Day 113.
Change From Baseline in the Mean of the Daily Average Pain Intensity Scores (on an 11-point NRS) Over the Entire 12-week MaintenanceBaseline, Daily scores over entire 12 week maintenance
Change From Baseline of the Weekly Mean of Current Pain Intensity (on an 11-point NRS) in the Evening and in the Morning, Respectively.Baseline, weekly mean
Patient Global Impression of Change Using a 7-point Verbal Rating Scale, on Day 29, Day 71 and Day 113 (Final Visit).Day 29, Day 71 and Day 113.
Proportion of Subjects Achieving Various Levels of Pain Improvement (Including 30% and 50%) Based on the Percent Change From Baseline to the Last 7 Days of the 12-week Maintenance on an 11-point NRS (Responder Analysis).Baseline, Last 7 days of 12-week maintenance
Change From Baseline in the Mean of the Daily Average Pain Intensity Scores (on an 11-point NRS) Over Each Week of Maintenance.Baseline; daily scores over each week of maintenance
Change From Baseline of the Weekly Mean of Night Pain Intensity (on an 11-point NRS).Baseline; weekly mean
Brief Pain Inventory Scores: Changes From Baseline to Day 8, Day 15, Day 22, Day 29, Day 43, Day 57, Day 71, Day 85, Day 99, and Day 113 (Final Visit).Baseline, weekly mean
Neuropathic Pain Symptoms Inventory: Changes From Baseline to Day 8, Day 15, Day 22, Day 29, Day 43, Day 57, Day 71, Day 85, Day 99 and Day 113 (Final Visit)Baseline, weekly mean
EuroQol-5 Dimension Health Questionnaire: Changes From Baseline to Day 29, Day 71 and Day 113 (Final Visit).Baseline, Day 29, Day 71 and Day 113.
Assessment of Each Item of the Leeds Sleep Evaluation Questionnaire: Changes From Baseline to Day 29, Day 71 and Day 113 (Final Visit).Baseline, Day 29, Day 71 and Day 113.
Time to Treatment Discontinuation Due to Lack of Efficacy.Baseline to time to treatment discontinuation
Assessment of Rescue Medication Usage During the 4-week Titration.4-week titration phase

Trial Locations

Locations (61)

Site 209

🇺🇸

Fullerton, California, United States

Site 136

🇺🇸

Deerfield Beach, Florida, United States

Site 137

🇺🇸

Deerfield Beach, Florida, United States

Site 128

🇺🇸

Chicago, Illinois, United States

Site 218

🇺🇸

Deerfield Beach, Florida, United States

Site 206

🇺🇸

Sarasota, Florida, United States

Site 117

🇺🇸

Fort Myers, Florida, United States

Site 223

🇺🇸

Chicago, Illinois, United States

Site 211

🇺🇸

Baltimore, Maryland, United States

Site 225

🇺🇸

Asheville, North Carolina, United States

Site 127

🇺🇸

Fairhope, Alabama, United States

Site 112

🇺🇸

Tucson, Arizona, United States

Site 129

🇺🇸

Escondido, California, United States

Site 202

🇺🇸

Northridge, California, United States

Site 208

🇺🇸

Northridge, California, United States

Site 219

🇺🇸

Northridge, California, United States

Site 116

🇺🇸

Santa Ana, California, United States

Site 118

🇺🇸

Santa Ana, California, United States

Site 121

🇺🇸

Santa Ana, California, United States

Site 133

🇺🇸

Santa Ana, California, United States

Site 126

🇺🇸

Vista, California, United States

Site 214

🇺🇸

Vista, California, United States

Site 201

🇺🇸

Waterbury, Connecticut, United States

Site 140

🇺🇸

Deerfield Beach, Florida, United States

Site 216

🇺🇸

Deerfield Beach, Florida, United States

Site 228

🇺🇸

Jupiter, Florida, United States

Site 212

🇺🇸

West Palm Beach, Florida, United States

Site 142

🇺🇸

Atlanta, Georgia, United States

Site 114

🇺🇸

Leawood, Kansas, United States

Site 113

🇺🇸

Las Vegas, Nevada, United States

Site 102

🇺🇸

Paducah, Kentucky, United States

Site 122

🇺🇸

Princeton, New Jersey, United States

Site 109

🇺🇸

Rochester, New York, United States

Site 230

🇺🇸

New York, New York, United States

Site 115

🇺🇸

High Point, North Carolina, United States

Site 227

🇺🇸

Canton, Ohio, United States

Site 111

🇺🇸

Toledo, Ohio, United States

Site 125

🇺🇸

Toledo, Ohio, United States

Site 104

🇺🇸

Philadelphia, Pennsylvania, United States

Site 106

🇺🇸

Philadelphia, Pennsylvania, United States

Site 213

🇺🇸

Corpus Christi, Texas, United States

Site 205

🇺🇸

Philadelphia, Pennsylvania, United States

Site 105

🇺🇸

Austin, Texas, United States

Site 123

🇺🇸

Houston, Texas, United States

Site 204

🇺🇸

Houston, Texas, United States

Site 110

🇺🇸

Houston, Texas, United States

Site 231

🇺🇸

Houston, Texas, United States

Site 210

🇺🇸

Houston, Texas, United States

Site 203

🇺🇸

San Francisco, California, United States

Site 233

🇺🇸

Cincinnati, Ohio, United States

Site 131

🇺🇸

San Antonio, Texas, United States

Site 221

🇺🇸

San Antonio, Texas, United States

Site 130

🇺🇸

Homewood, Alabama, United States

Site 135

🇺🇸

Long Beach, California, United States

Site 215

🇺🇸

San Antonio, Texas, United States

Site 226

🇺🇸

Orlando, Florida, United States

Site 124

🇺🇸

Jacksonville, Florida, United States

Site 139

🇺🇸

Provo, Utah, United States

Site 108

🇺🇸

East Bridgewater, Massachusetts, United States

Site 217

🇺🇸

Deerfield Beach, Florida, United States

Site 101

🇺🇸

Orlando, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath